These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 18995178)

  • 1. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction.
    Parissis JT; Adamopoulos S; Venetsanou K; Kostakis G; Rigas A; Karas SM; Kremastinos D
    Eur Cytokine Netw; 2004; 15(2):139-44. PubMed ID: 15319174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.
    Birner CM; Ulucan C; Fredersdorf S; Rihm M; Löwel H; Stritzke J; Schunkert H; Hengstenberg C; Holmer S; Riegger G; Luchner A
    Cytokine; 2007 Nov; 40(2):89-97. PubMed ID: 17920926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group).
    Savoye C; Equine O; Tricot O; Nugue O; Segrestin B; Sautière K; Elkohen M; Pretorian EM; Taghipour K; Philias A; Aumégeat V; Decoulx E; Ennezat PV; Bauters C;
    Am J Cardiol; 2006 Nov; 98(9):1144-9. PubMed ID: 17056315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and renal function influence plasma levels of copeptin in healthy individuals.
    Bhandari SS; Loke I; Davies JE; Squire IB; Struck J; Ng LL
    Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
    Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
    Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
    Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
    Abbate A; Kontos MC; Grizzard JD; Biondi-Zoccai GG; Van Tassell BW; Robati R; Roach LM; Arena RA; Roberts CS; Varma A; Gelwix CC; Salloum FN; Hastillo A; Dinarello CA; Vetrovec GW;
    Am J Cardiol; 2010 May; 105(10):1371-1377.e1. PubMed ID: 20451681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late ventricular remodeling in non-reperfused acute myocardial infarction in humans is predicted by angiotensin II type 1 receptor density on blood platelets.
    Maczewski M; Borys M; Kacprzak P; Gdowski T; Kowalewski M; Wojciechowski D
    Int J Cardiol; 2008 Jun; 127(1):57-63. PubMed ID: 17651844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of novel mediators of inflammation in left ventricular remodeling in patients with acute myocardial infarction: do they affect the outcome of patients?
    Oren H; Erbay AR; Balci M; Cehreli S
    Angiology; 2007; 58(1):45-54. PubMed ID: 17351157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased body temperature after reperfused acute myocardial infarction is associated with adverse left ventricular remodeling.
    Naito K; Anzai T; Yoshikawa T; Maekawa Y; Sugano Y; Kohno T; Mahara K; Okabe T; Asakura Y; Ogawa S
    J Card Fail; 2007 Feb; 13(1):25-33. PubMed ID: 17339000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental value of copeptin for rapid rule out of acute myocardial infarction.
    Reichlin T; Hochholzer W; Stelzig C; Laule K; Freidank H; Morgenthaler NG; Bergmann A; Potocki M; Noveanu M; Breidthardt T; Christ A; Boldanova T; Merki R; Schaub N; Bingisser R; Christ M; Mueller C
    J Am Coll Cardiol; 2009 Jun; 54(1):60-8. PubMed ID: 19555842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function.
    Suezawa C; Kusachi S; Murakami T; Toeda K; Hirohata S; Nakamura K; Yamamoto K; Koten K; Miyoshi T; Shiratori Y
    J Lab Clin Med; 2005 Jan; 145(1):33-40. PubMed ID: 15668659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.